Shares of Japan’s Sumitomo Pharma fell over 15% on the back of profit-taking after a specialist panel endorsed its iPS cell-based therapy for Parkinson’s disease.
North Korea kicks off Party Congress with pomp and circumstance in photos
...
Read moreDetails



